Sleep Europe 2026, the 28th Congress of the European Sleep Research Society, will take place in Maastricht, the Netherlands, from October 20 to 23, 2026. Held every two years, the congress brings together clinicians, researchers, scientists and other sleep professionals to share and discuss the latest advances in sleep medicine and sleep research.

Discover the latest research on daridorexant at Sleep Europe 2026, including new findings in pediatric insomnia, real-world evidence, adult insomnia and the evolving treatment landscape.

• Efficacy and safety of daridorexant in individuals with insomnia with short sleep duration
• ProDiGyA: Interim analysis of a real-world, prospective, noninterventional study evaluating daridorexant in patients with insomnia disorder
• Effect of daridorexant on quality of life and work productivity in patients with insomnia in a Canadian real-world setting
• Impact of the introduction of dual orexin receptor antagonists on the usage of prescription medications for insomnia

• POSTER: The dual orexin receptor antagonist daridorexant in pediatric insomnia disorder
• PRESENTATION: The dual orexin receptor antagonist daridorexant in pediatric insomnia disorder

Evolving pharmacological insomnia treatment and the role of dual orexin receptor antagonists (DORAs): A field in transition 

Thursday, 22 October, 2026 | 12:45–13:45

Level 0, Room 0.10

• ESRS 2026 Symposium Flyer

Forum Talk: Targeting the orexin pathway to treat insomnia disorder in patients with cognitive decline 

• Sunday, June 29 from 13:45-14:00

Lunch Symposium: Managing insomnia disorder to preserve brain health 

• Monday, March 30 from 12:45-13:45

• EAN 2026 Symposium Flyer

• Efficacy and safety of daridorexant for the treatment of insomnia disorder  in women of menopausal transition age: Insights from a randomized  controlled trial

Wednesday, 4 March | 15:45–17:15

Rome, Italy

• ISGE 2026 Symposium Flyer